Inactive Instrument
Intervacc AB (publ) Stock Nasdaq Stockholm
Stocks
SE0009607252
Biotechnology & Medical Research
| Market Cap | 381M 39.32M 34.45M 31.98M 29.39M 55.38M 3.79B 56.2M 149M 1.86B 148M 144M 6.41B | P/E 2026 * |
-5.08x | P/E 2027 * | -5.08x |
|---|---|---|---|---|---|
| Enterprise Value | 288M 29.72M 26.04M 24.18M 22.22M 41.87M 2.87B 42.48M 113M 1.4B 112M 109M 4.85B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | 10.6x |
| Free-Float |
80.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.15% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 2026-02-04 | |
Jan Persson
DFI | Director of Finance/CFO | - | 2020-02-05 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2020-06-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Emil Billbäck
CHM | Chairman | 56 | 2026-05-12 |
| Director/Board Member | 72 | 2023-12-31 | |
| Director/Board Member | 68 | 2024-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.15% | -1.02% | - | - | 40.01M | |
| -0.43% | -4.26% | +52.09% | +85.69% | 55.57B | |
| -0.24% | +1.04% | +55.76% | +54.21% | 54.26B | |
| -0.54% | -0.17% | -17.60% | -15.43% | 23.35B | |
| -1.82% | -2.89% | +3.61% | +405.88% | 23.54B | |
| +0.88% | +0.10% | +36.90% | -2.93% | 20.32B | |
| +3.16% | +0.79% | +37.98% | -31.36% | 17.36B | |
| -0.19% | -0.77% | +38.27% | +549.75% | 15.59B | |
| +0.43% | -10.61% | +175.63% | +299.61% | 14.96B | |
| -2.03% | -1.03% | +23.63% | +179.23% | 14.11B | |
| Average | -0.20% | -0.71% | +45.14% | +169.40% | 26.56B | |
| Weighted average by Cap. | -0.12% | -0.44% | +44.18% | +133.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.7M 1.83M 1.6M 1.49M 1.37M 2.57M 176M 2.61M 6.93M 86.24M 6.86M 6.71M 298M | 30.05M 3.1M 2.72M 2.52M 2.32M 4.37M 299M 4.43M 11.76M 146M 11.64M 11.39M 506M |
| Net income | -80.8M -8.34M -7.31M -6.78M -6.23M -11.74M -805M -11.92M -31.62M -394M -31.3M -30.63M -1.36B | -83.65M -8.63M -7.56M -7.02M -6.45M -12.16M -833M -12.34M -32.74M -408M -32.41M -31.71M -1.41B |
| Net Debt | -93M -9.6M -8.41M -7.81M -7.17M -13.52M -926M -13.72M -36.4M -453M -36.03M -35.25M -1.57B | -63M -6.5M -5.7M -5.29M -4.86M -9.16M -627M -9.29M -24.66M -307M -24.41M -23.88M -1.06B |
Employees
-
Calendar
